Yoo‐Na Kim

488 total citations
38 papers, 272 citations indexed

About

Yoo‐Na Kim is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Yoo‐Na Kim has authored 38 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Reproductive Medicine and 12 papers in Obstetrics and Gynecology. Recurrent topics in Yoo‐Na Kim's work include Ovarian cancer diagnosis and treatment (16 papers), Cancer Genomics and Diagnostics (12 papers) and PARP inhibition in cancer therapy (12 papers). Yoo‐Na Kim is often cited by papers focused on Ovarian cancer diagnosis and treatment (16 papers), Cancer Genomics and Diagnostics (12 papers) and PARP inhibition in cancer therapy (12 papers). Yoo‐Na Kim collaborates with scholars based in South Korea, United States and Austria. Yoo‐Na Kim's co-authors include Jung‐Yun Lee, Ja‐Young Kwon, Sang Wun Kim, Sunghoon Kim, Eun‐Cheol Park, Dong‐Woo Choi, Dong Seop Kim, Yong Jae Lee, Young Tae Kim and Su Jeong You and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Yoo‐Na Kim

35 papers receiving 268 citations

Peers

Yoo‐Na Kim
Setareh Akhavan Iran
Marianne Hinkula Finland
Philippos Edimiris Germany
Maria Maddalena Latocca Italy
Ioan Sas Romania
K. Penner United States
Tomomi Egawa‐Takata Japan
Claudio Gustavino Italy
Louise Flynn United States
Frederico Soares Falcetta Brazil
Setareh Akhavan Iran
Yoo‐Na Kim
Citations per year, relative to Yoo‐Na Kim Yoo‐Na Kim (= 1×) peers Setareh Akhavan

Countries citing papers authored by Yoo‐Na Kim

Since Specialization
Citations

This map shows the geographic impact of Yoo‐Na Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoo‐Na Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoo‐Na Kim more than expected).

Fields of papers citing papers by Yoo‐Na Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoo‐Na Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoo‐Na Kim. The network helps show where Yoo‐Na Kim may publish in the future.

Co-authorship network of co-authors of Yoo‐Na Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yoo‐Na Kim. A scholar is included among the top collaborators of Yoo‐Na Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoo‐Na Kim. Yoo‐Na Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Yoo‐Na, Eunhyang Park, Yong Jae Lee, et al.. (2025). Genomic Profiling in Patients with Endometrial Cancer by Deep Sequencing of Vaginal Swabs and Plasma. Clinical Cancer Research. 31(14). 2978–2988.
2.
Park, Junsik, Dahye Lee, So Yeon Kim, et al.. (2025). Prognostic implications of HER2 in ovarian cancer: Associations with homologous recombination deficiency and folate receptor alpha expression. Gynecologic Oncology. 203. 151–157.
3.
4.
Kim, Se Ik, Je‐Gun Joung, Yoo‐Na Kim, et al.. (2024). Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial. Gynecologic Oncology. 182. 7–14. 4 indexed citations
5.
Kim, Yoo‐Na, et al.. (2024). RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer. Frontiers in Oncology. 14. 1351778–1351778. 3 indexed citations
6.
Kim, Yoo‐Na, Jieun Seo, Yong Jae Lee, et al.. (2023). Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA -Mutated Ovarian Cancer. Clinical Cancer Research. 29(14). 2725–2734. 19 indexed citations
7.
Park, Junsik, Jung Chul Kim, Mi‐Ran Lee, et al.. (2023). Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer. British Journal of Cancer. 129(11). 1841–1851. 6 indexed citations
8.
Kim, Yoo‐Na, et al.. (2023). Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience. Journal of Gynecologic Oncology. 34(6). e70–e70. 1 indexed citations
9.
10.
Kim, Yoo‐Na, Saeam Shin, Yong Jae Lee, et al.. (2023). Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer. Cancer Research. 84(3). 468–478. 23 indexed citations
11.
Kim, Yoo‐Na, Je‐Gun Joung, Eunhyang Park, et al.. (2023). Randomized, two‐arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045. International Journal of Cancer. 153(12). 2032–2044. 6 indexed citations
12.
Kim, Hye Min, Seung-Jae Noh, Jeong Yeon Kim, et al.. (2023). Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer. Scientific Reports. 13(1). 22482–22482. 7 indexed citations
13.
14.
Kim, Yoo‐Na, Jung Chul Kim, Young Shin Chung, et al.. (2022). Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study. Gynecologic Oncology. 165(1). 75–81. 2 indexed citations
15.
Barrett, James E., Chiara Herzog, Yoo‐Na Kim, et al.. (2022). Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock. Genome biology. 23(1). 52–52. 7 indexed citations
16.
Kim, Yoo‐Na, Kyunglim Lee, Eunhyang Park, et al.. (2022). Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer. Frontiers in Oncology. 12. 942735–942735. 7 indexed citations
17.
Kim, Yoo‐Na & Young Tae Kim. (2022). Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues. Obstetrics & Gynecology Science. 65(5). 395–405. 6 indexed citations
18.
19.
Kim, Yoo‐Na, et al.. (2021). Comparison between prepubertal and postpubertal patients with obstructed hemivagina and ipsilateral renal anomaly syndrome. Journal of Pediatric Urology. 17(5). 652.e1–652.e7. 10 indexed citations
20.
Kim, Yoo‐Na, Dong‐Woo Choi, Dong Seop Kim, Eun‐Cheol Park, & Ja‐Young Kwon. (2021). Maternal age and risk of early neonatal mortality: a national cohort study. Scientific Reports. 11(1). 814–814. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Setareh Akhavan Breakdown of academic impact, for papers by Marianne Hinkula Breakdown of academic impact, for papers by Philippos Edimiris Breakdown of academic impact, for papers by Maria Maddalena Latocca Breakdown of academic impact, for papers by Ioan Sas Breakdown of academic impact, for papers by K. Penner Breakdown of academic impact, for papers by Tomomi Egawa‐Takata Breakdown of academic impact, for papers by Claudio Gustavino Breakdown of academic impact, for papers by Louise Flynn Breakdown of academic impact, for papers by Frederico Soares Falcetta
Rankless by CCL
2026